These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1768267)

  • 1. Molecular basis for binding promiscuity of antagonist drugs.
    LaBella FS
    Biochem Pharmacol; 1991 Dec; 42 Suppl():S1-8. PubMed ID: 1768267
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug promiscuity].
    Guo ZR
    Yao Xue Xue Bao; 2011 Apr; 46(4):361-9. PubMed ID: 21751487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular determinants of drug-receptor binding kinetics.
    Pan AC; Borhani DW; Dror RO; Shaw DE
    Drug Discov Today; 2013 Jul; 18(13-14):667-73. PubMed ID: 23454741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand efficiency indices as guideposts for drug discovery.
    Abad-Zapatero C; Metz JT
    Drug Discov Today; 2005 Apr; 10(7):464-9. PubMed ID: 15809192
    [No Abstract]   [Full Text] [Related]  

  • 5. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promiscuity: what protects us, perplexes us.
    Redinbo MR
    Drug Discov Today; 2004 May; 9(10):431-2. PubMed ID: 15109946
    [No Abstract]   [Full Text] [Related]  

  • 7. Modeling promiscuity based on in vitro safety pharmacology profiling data.
    Azzaoui K; Hamon J; Faller B; Whitebread S; Jacoby E; Bender A; Jenkins JL; Urban L
    ChemMedChem; 2007 Jun; 2(6):874-80. PubMed ID: 17492703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physics-based methods for studying protein-ligand interactions.
    Huang N; Jacobson MP
    Curr Opin Drug Discov Devel; 2007 May; 10(3):325-31. PubMed ID: 17554859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lead optimization via high-throughput molecular docking.
    Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
    Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling of hydration in drug design.
    Mancera RL
    Curr Opin Drug Discov Devel; 2007 May; 10(3):275-80. PubMed ID: 17554853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Turning from monogamy to strategic promiscuity.
    Stark H
    Drug Discov Today; 2004 Sep; 9(17):736-7. PubMed ID: 15450238
    [No Abstract]   [Full Text] [Related]  

  • 12. Contributions of molecular properties to drug promiscuity.
    Tarcsay Á; Keserű GM
    J Med Chem; 2013 Mar; 56(5):1789-95. PubMed ID: 23356819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pocket extraction on proteins via the Voronoi diagram of spheres.
    Kim D; Cho CH; Cho Y; Ryu J; Bhak J; Kim DS
    J Mol Graph Model; 2008 Apr; 26(7):1104-12. PubMed ID: 18023220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modulation of the receptors during interaction with pharmacologically active substances (review of the literature)].
    Seĭfulla RD
    Farmakol Toksikol; 1976; 39(4):492-500. PubMed ID: 1027576
    [No Abstract]   [Full Text] [Related]  

  • 15. Advances in structure-based drug design.
    Schaffhausen J
    Trends Pharmacol Sci; 2012 May; 33(5):223. PubMed ID: 22503451
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of molecular dynamics on drug design: applications for the characterization of ligand-macromolecule complexes.
    Mortier J; Rakers C; Bermudez M; Murgueitio MS; Riniker S; Wolber G
    Drug Discov Today; 2015 Jun; 20(6):686-702. PubMed ID: 25615716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commentary: nonspecific protein binding versus membrane partitioning: it is not just semantics.
    Nagar S; Korzekwa K
    Drug Metab Dispos; 2012 Sep; 40(9):1649-52. PubMed ID: 22711748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug design by the method of receptor fit.
    Goodford PJ
    J Med Chem; 1984 May; 27(5):558-64. PubMed ID: 6716396
    [No Abstract]   [Full Text] [Related]  

  • 19. Ranking poses in structure-based lead discovery and optimization: current trends in scoring function development.
    Rajamani R; Good AC
    Curr Opin Drug Discov Devel; 2007 May; 10(3):308-15. PubMed ID: 17554857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to design a drug for the disordered proteins?
    Chen CY; Tou WI
    Drug Discov Today; 2013 Oct; 18(19-20):910-5. PubMed ID: 23643489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.